Gene · 54822
Papers2,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma. | Cancers (Basel) | 2022 | 36230742 | PubTator, text mining | PubMed |
| Extremely Early-Onset Frontotemporal Dementia: A Case Report and Literature Review. | J Alzheimers Dis | 2022 | 36214000 | PubTator, text mining | PubMed |
| Ex vivo exposures to arsenite and its methylated trivalent metabolites alter gene transcription in mouse sperm cells. | Toxicol Appl Pharmacol | 2022 | 36209798 | PubTator, text mining | PubMed |
| The omega of TRPM7 channels in trigeminal neuralgia. | Pflugers Arch | 2022 | 36197528 | PubTator, text mining | PubMed |
| A risk signature based on necroptotic-process-related genes predicts prognosis and immune therapy response in kidney cell carcinoma. | Front Immunol | 2022 | 36189275 | PubTator, text mining | PubMed |
| Development and validation of a TRP-related gene signature for overall survival prediction in lung adenocarcinoma. | Front Genet | 2022 | 36186485 | PubTator, text mining | PubMed |
| Computational and functional studies of the PI(4,5)P2 binding site of the TRPM3 ion channel reveal interactions with other regulators. | J Biol Chem | 2022 | 36181791 | PubTator, text mining | PubMed |
| The urothelium: a multi-faceted barrier against a harsh environment. | Mucosal Immunol | 2022 | 36180582 | PubTator, text mining | PubMed |
| Aberrant calcium signalling downstream of mutations in TP53 and the PI3K/AKT pathway genes promotes disease progression and therapy resistance in triple negative breast cancer. | Cancer Drug Resist | 2022 | 36176752 | PubTator, text mining | PubMed |
| The metabolic genomic atlas reveals potential drivers and clinically relevant insights into the etiology of esophageal squamous cell carcinoma. | Theranostics | 2022 | 36168622 | PubTator, text mining | PubMed |
| Knockdown of TRPM7 attenuates apoptosis and inflammation in neonatal necrotizing enterocolitis model cell IEC-6 via modulating TLR4/NF-κB and MEK/ERK pathways. | Iran J Basic Med Sci | 2022 | 36159330 | PubTator, text mining | PubMed |
| The interplay between physical cues and mechanosensitive ion channels in cancer metastasis. | Front Cell Dev Biol | 2022 | 36158191 | PubTator, text mining | PubMed |
| Circ_0021155 can participate in the phenotypic transformation of human vascular smooth muscle cells via the miR-4459/TRPM7 axis. | Biochem Biophys Res Commun | 2022 | 36155059 | PubTator, text mining | PubMed |
| Crosstalk between Ca2+ Signaling and Cancer Stemness: The Link to Cisplatin Resistance. | Int J Mol Sci | 2022 | 36142596 | PubTator, text mining | PubMed |
| Hesperidin Suppresses the Proliferation of Prostate Cancer Cells by Inducing Oxidative Stress and Disrupting Ca2+ Homeostasis. | Antioxidants (Basel) | 2022 | 36139707 | PubTator, text mining | PubMed |
| Transient Receptor Potential (TRP) Channels in Airway Toxicity and Disease: An Update. | Cells | 2022 | 36139480 | PubTator, text mining | PubMed |
| Mass spectrometric analysis of TRPM6 and TRPM7 from small intestine of omeprazole-induced hypomagnesemic rats. | Front Oncol | 2022 | 36110961 | PubTator, text mining | PubMed |
| A TRPM7 mutation linked to familial trigeminal neuralgia: Omega current and hyperexcitability of trigeminal ganglion neurons. | Proc Natl Acad Sci U S A | 2022 | 36095216 | PubTator, text mining | PubMed |
| Osteogenic differentiation of pre-conditioned bone marrow mesenchymal stem cells with Nisin on modified poly-L-lactic-acid nanofibers. | Regen Ther | 2022 | 36092506 | PubTator, text mining | PubMed |
| Integrated analysis of the M2 macrophage-related signature associated with prognosis in ovarian cancer. | Front Oncol | 2022 | 36091124 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54822/papers?page=24